Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Young Patients with Advanced GIST
NCT01396148Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2012
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of sunitinib in gastrointestinal stromal tumor (GIST), sponsored by Pfizer. Started Jun 2012; status: completed.
02
Drugs
sunitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01396148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01396148.